Author:
Hua Yue,Wang Yuan,Kang Xue,Xu Fan,Han Zhen,Zhang Chong,Wang Zhao-Yang,Liu Jun-Qi,Zhao Xueli,Chen Xiaoyuan,Zang Shuang-Quan
Abstract
Abstract
Background
As cancer is one of the main leading causes of mortality, a series of monotherapies such as chemotherapy, gene therapy and radiotherapy have been developed to overcome this thorny problem. However, a single treatment approach could not achieve satisfactory effect in many experimental explorations.
Results
In this study, we report the fabrication of cyclic RGD peptide (cRGD) modified Au4-iron oxide nanoparticle (Au4-IO NP-cRGD) based on aggregation-induced emission (AIE) as a multifunctional theranostic system. Besides Au4 cluster-based fluorescence imaging and enhanced radiotherapy, iron oxide (IO) nanocluster could realize magnetic resonance (MR) imaging and Fenton reaction-based chemotherapy. Abundant toxic reactive oxygen species generated from X-ray irradiation and in situ tumor-specific Fenton reaction under acidic microenvironment leads to the apoptotic and necrotic death of cancer cells. In vivo studies demonstrated good biocompatibility of Au4-IO NP-cRGD and a high tumor suppression rate of 81.1% in the synergistic therapy group.
Conclusions
The successful dual-modal imaging and combined tumor therapy demonstrated AIE as a promising strategy for constructing multifunctional cancer theranostic platform.
Graphical Abstract
Funder
China National Funds for Distinguished Young Scientists
Key Programme
Young Scientists Fund
Postdoctoral Research Foundation of China
the Program for Science & Technology Innovation Talents in Universities of Henan Province
the National University of Singapore Start-up Grant
NUS School of Medicine Nanomedicine Translational Research Programme
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献